Skip to main content
OpenTrials
Recruiting

NCT Number: NCT03272620

Atrial Fibrillation at the Viennese University Emergency Department

The results of this study could imply that a atrial fibrillation registry, as a tool for structured diagnosis and therapy in patients with atrial fibrillation, may improve patient care for this rapidly growing population.

Recruiting

Interested in participating?

Request Info

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Emergency Department, Medical University Vienna

Vienna, 1090, Austria

Location status: Recruiting

Location contact

Alexander Simon, Dr.

CONTACT

[email protected]

Jan Niederdöckl, Dr.

CONTACT

[email protected]

About this study

Atrial fibrillation is the most common cardiac arrhythmia and is associated with increased cardiovascular morbidity and mortality, with stroke being an especially important and potentially devastating complication. The number of patients with atrial fibrillation is likely to increase 2.5-fold during the next 50 years, reflecting the growing proportion of elderly individuals. Emergency departments play a central role in diagnosis and treatment (rhythm and rate control, initiation of anticoagulatory therapy for stroke prevention) of atrial fibrillation. Additionally, embolic (e.g. stroke, mesenteric ischemia) complications of atrial fibrillation and bleeding complications (e.g. gastrointestinal and intracranial) of anticoagulatory therapy are likewise treated at emergency departments.

Therefor the investigators hypothesis implies that the atrial fibrillation registry could serve as a tool for structured diagnosis and therapy in patients with atrial fibrillation and therefore may improve patient care. Additionally, diagnostic and therapeutic shortcomings by analyzing registry data may be detected.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patients with atrial fibrillation treated at the Emergency Department of the Medical University of Vienna
  • Signed consent

Exclusion criteria

  • Inclusion criteria not met

Treatment and study plan

Primary outcomes

  1. Number of participants with major adverse cardiac events

    Time frame: Follow up (10 years)

    frequency distribution

Secondary outcomes

  1. Number of successfully conducted cardioversions

    Time frame: Follow up (10 years)

    frequency distribution

Study contacts

Contact information is provided by the study sponsor or research team.

Alexander Simon, Dr.

CONTACT

[email protected]

Jan Niederdöckl, Dr.

CONTACT

jan.niederdö[email protected]

Sponsors and collaborators

Lead sponsor

Medical University of Vienna

Other

Registry information

Official study title

Atrial Fibrillation Registry at the Emergency Department of the Medical University of Vienna: A Tool for Structured Diagnosis and Treatment

Important dates

Study start
2014
Primary completion
2020
Study completion
2030
First posted
Sep 5, 2017
Registry last updated
Sep 5, 2017

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.